Fairness in Nursing Home Arbitration Act

Forced Arbitration Injustice Repeal Act (FAIR). Protecting the Employment Rights of Service Members Act (PERSA). Justice for Servicemembers Act. HR 7119 Fairness in Nursing Home Arbitration Act. Bill to prohibit forced arbitration in health insurance contracts. H.R. 7194/ S3725 PFAS Accountability Act of 2024. Nursing Home Improvement and Accountability Act. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. SPEAK OUT Act. Consolidated Appropriations Act, 2023, with regard to cosmetics legislation. Updated Drug labeling for Patient Safety Act. HR 4120 Protecting Older Americans Act. S 1979 Protecting Older American Act. HR 3038 Ending Forced Arbitration of Race Discrimination Act of 2023. S 1408 Ending Forced Arbitration of Race Discrimination Act of 2023. Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to e-cigarettes safety and regulation. General lobbying with regard to the FDA proposal regarding the testing of talc for asbestos/Chrysotile rule. General lobbying with regard to FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying with regard to glyphosate safety. General lobbying with regard to drug pricing. S. 269: Protect America's Children from Toxic Pesticides Act. HR 4417/S2019 Ending Agricultural Trade Suppression. HR 4288 Agricultural Labeling Uniformity Act. General lobbying with regard to PFAS. General lobbying with regard to asbestos. General lobbying with regard to talc. S 4303 Baby Food Safety Act. General lobbying with regard to corporate accountability in nursing homes. H.R. 8998 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2025 with specific regard to FIFRA preemption. HR 10230 Good Samaritan Menstrual Products Act with specific regard to liability immunity.

Client expense: $1,190,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Forced Arbitration Injustice Repeal Act (FAIR). Protecting the Employment Rights of Service Members Act (PERSA). Justice for Servicemembers Act. HR 7119 Fairness in Nursing Home Arbitration Act. Bill to prohibit forced arbitration in health insurance contracts. H.R. 7194/ S3725 PFAS Accountability Act of 2024. Nursing Home Improvement and Accountability Act. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. SPEAK OUT Act. Consolidated Appropriations Act, 2023, with regard to cosmetics legislation. Updated Drug labeling for Patient Safety Act. HR 4120 Protecting Older Americans Act. S 1979 Protecting Older American Act. HR 3038 Ending Forced Arbitration of Race Discrimination Act of 2023. S 1408 Ending Forced Arbitration of Race Discrimination Act of 2023. Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to e-cigarettes safety and regulation. General lobbying with regard to the FDA proposal regarding the testing of talc for asbestos/Chrysotile rule. General lobbying with regard to FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying with regard to glyphosate safety. General lobbying with regard to drug pricing. S. 269: Protect America's Children from Toxic Pesticides Act. HR 4417/S2019 Ending Agricultural Trade Suppression. HR 4288 Agricultural Labeling Uniformity Act. General lobbying with regard to PFAS. General lobbying with regard to asbestos. General lobbying with regard to talc. S 4303 Baby Food Safety Act. General lobbying with regard to corporate accountability in nursing homes. H.R. 8998 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2025 with specific regard to FIFRA preemption.

Client expense: $1,170,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Forced Arbitration Injustice Repeal Act (FAIR). Protecting the Employment Rights of Service Members Act (PERSA). Justice for Servicemembers Act. HR 7119 Fairness in Nursing Home Arbitration Act. Bill to prohibit forced arbitration in health insurance contracts. H.R. 7194/ S3725 PFAS Accountability Act of 2024. Nursing Home Improvement and Accountability Act. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. SPEAK OUT Act. Consolidated Appropriations Act, 2023, with regard to cosmetics legislation. Updated Drug labeling for Patient Safety Act. HR 4120 Protecting Older Americans Act. S 1979 Protecting Older American Act. HR 3038 Ending Forced Arbitration of Race Discrimination Act of 2023. S 1408 Ending Forced Arbitration of Race Discrimination Act of 2023. Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to e-cigarettes safety and regulation. General lobbying with regard to the FDA proposal regarding the testing of talc for asbestos/Chrysotile rule. General lobbying with regard to FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying with regard to glyphosate safety. General lobbying with regard to drug pricing. S. 269: Protect America's Children from Toxic Pesticides Act. HR 4417/S2019 Ending Agricultural Trade Suppression. HR 4288 Agricultural Labeling Uniformity Act. General lobbying with regard to PFAS. General lobbying with regard to asbestos. General lobbying with regard to talc. S 4303 Baby Food Safety Act. General lobbying with regard to corporate accountability in nursing homes.

Client expense: $1,340,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE